TriangleHEALTH PROFESSIONAL · SOURCE READING
Tyrosine kinase inhibitor (TKI) therapy
Source: Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 25, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Metastatic Breast Cancer / Metastatic HER2-Positive Breast Cancer
The FDA has approved several TKIs for metastatic HER2-positive breast cancer.
Continue within this section
Preserved source evidence · Not medical advice